Canada adopted a national artificial intelligence (AI) strategy in 2017 and is now considered one of the most advanced countries in this field, as it continues to invest in and attract researchers, students, and experts to build a stronger community.
Considering the importance of AI innovation in healthcare in Canada and the impact that AI discovery and application can have for patients and the healthcare system, Roche Canada created a center of excellence in artificial intelligence called AI with Roche (AIR), in collaboration with the three national AI institutes under the CIFAR Pan-Canadian AI Strategy - Amii, Mila and the Vector Institute.
Joining forces with experts of the research community aims to improve those outcomes from AI applied in healthcare.
Some of the panellists :
- Professor Yoshua Bengio, Scientific Director, Mila;
- Richard S. Sutton, Fellow & Chief Scientific Advisor, Amii;
- Dr. Garth Gibson, President and CEO, Vector Institute;
- Fanny Sie, Head of AI and Digital Health, Roche Canada.
Join us for a virtual discussion on Wednesday, September 15th from 1:00 - 3:30 PM EDT about the potential of artificial intelligence in health, public-private partnerships and collaboration, and possibilities to improve health outcomes for populations and patients across Canada by leveraging AI.
Meet the AIR collaborators and hear institutional and political perspectives about the future of artificial intelligence in the healthcare system.
It is the place to be on September 15th. An event presented by EFFERVESCENCE!
